332 related articles for article (PubMed ID: 20079806)
1. Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy.
Li F; Sethi G
Biochim Biophys Acta; 2010 Apr; 1805(2):167-80. PubMed ID: 20079806
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of stable inducible up-regulation of nuclear factor-kappaB by tumor necrosis factor exposure confers increased radiation resistance without increased transformation in breast cancer cells.
Braunstein S; Formenti SC; Schneider RJ
Mol Cancer Res; 2008 Jan; 6(1):78-88. PubMed ID: 18234964
[TBL] [Abstract][Full Text] [Related]
3. Using NF-κB as a molecular target for theranostics in radiation oncology research.
Liu YC; Chiang IT; Hsu FT; Hwang JJ
Expert Rev Mol Diagn; 2012 Mar; 12(2):139-46. PubMed ID: 22369374
[TBL] [Abstract][Full Text] [Related]
4. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation.
Cusack JC; Liu R; Baldwin AS
Cancer Res; 2000 May; 60(9):2323-30. PubMed ID: 10811101
[TBL] [Abstract][Full Text] [Related]
5. Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341).
Kamer S; Ren Q; Dicker AP
Arch Gynecol Obstet; 2009 Jan; 279(1):41-6. PubMed ID: 18461345
[TBL] [Abstract][Full Text] [Related]
6. Targeting the NF-κB pathway in cancer therapy.
Erstad DJ; Cusack JC
Surg Oncol Clin N Am; 2013 Oct; 22(4):705-46. PubMed ID: 24012396
[TBL] [Abstract][Full Text] [Related]
7. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
8. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
9. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB.
Wang CY; Cusack JC; Liu R; Baldwin AS
Nat Med; 1999 Apr; 5(4):412-7. PubMed ID: 10202930
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor-κB activity in human oral cancer cells.
Tamatani T; Takamaru N; Hara K; Kinouchi M; Kuribayashi N; Ohe G; Uchida D; Fujisawa K; Nagai H; Miyamoto Y
Int J Oncol; 2013 Mar; 42(3):935-44. PubMed ID: 23340716
[TBL] [Abstract][Full Text] [Related]
11. Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes.
Chen X; Shen B; Xia L; Khaletzkiy A; Chu D; Wong JY; Li JJ
Cancer Res; 2002 Feb; 62(4):1213-21. PubMed ID: 11861406
[TBL] [Abstract][Full Text] [Related]
12. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy.
Holcomb B; Yip-Schneider M; Schmidt CM
Pancreas; 2008 Apr; 36(3):225-35. PubMed ID: 18362834
[TBL] [Abstract][Full Text] [Related]
13. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.
Aggarwal BB; Vijayalekshmi RV; Sung B
Clin Cancer Res; 2009 Jan; 15(2):425-30. PubMed ID: 19147746
[TBL] [Abstract][Full Text] [Related]
14. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
15. Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?
Verzella D; Fischietti M; Capece D; Vecchiotti D; Del Vecchio F; Cicciarelli G; Mastroiaco V; Tessitore A; Alesse E; Zazzeroni F
Curr Drug Targets; 2016; 17(3):311-20. PubMed ID: 26343112
[TBL] [Abstract][Full Text] [Related]
16. The Accomplices of NF-κB Lead to Radioresistance.
Bai M; Ma X; Li X; Wang X; Mei Q; Li X; Wu Z; Han W
Curr Protein Pept Sci; 2015; 16(4):279-94. PubMed ID: 25929862
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappaB inhibition.
Cheng Q; Lee HH; Li Y; Parks TP; Cheng G
Oncogene; 2000 Oct; 19(42):4936-40. PubMed ID: 11039911
[TBL] [Abstract][Full Text] [Related]
19. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
Dhandapani KM; Mahesh VB; Brann DW
J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappa B and cancer: its role in prevention and therapy.
Bharti AC; Aggarwal BB
Biochem Pharmacol; 2002 Sep; 64(5-6):883-8. PubMed ID: 12213582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
